SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-048835
Filing Date
2020-04-21
Accepted
2020-04-20 18:58:47
Documents
5
Period of Report
2020-04-20
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a20-14800_68k.htm 8-K 24283
2 EX-99.1 a20-14800_6ex99d1.htm EX-99.1 31355
3 GRAPHIC g148006mmi001.gif GRAPHIC 2150
4 GRAPHIC g148006mmi002.gif GRAPHIC 2160
5 GRAPHIC g148006mmi003.gif GRAPHIC 2167
  Complete submission text file 0001104659-20-048835.txt   66205
Mailing Address 100 SOUTH SAUNDERS RD SUITE 300 LAKE FOREST IL 60045
Business Address 100 SOUTH SAUNDERS RD SUITE 300 LAKE FOREST IL 60045 (224) 419-7106
Assertio Therapeutics, Inc (Filer) CIK: 0001005201 (see all company filings)

IRS No.: 943229046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-13111 | Film No.: 20803667
SIC: 2834 Pharmaceutical Preparations